359 related articles for article (PubMed ID: 19655751)
1. Class I major histocompatibility complexes loaded by a periodate trigger.
Rodenko B; Toebes M; Celie PH; Perrakis A; Schumacher TN; Ovaa H
J Am Chem Soc; 2009 Sep; 131(34):12305-13. PubMed ID: 19655751
[TBL] [Abstract][Full Text] [Related]
2. Generation of peptide-MHC class I complexes through UV-mediated ligand exchange.
Rodenko B; Toebes M; Hadrup SR; van Esch WJ; Molenaar AM; Schumacher TN; Ovaa H
Nat Protoc; 2006; 1(3):1120-32. PubMed ID: 17406393
[TBL] [Abstract][Full Text] [Related]
3. Design and use of conditional MHC class I ligands.
Toebes M; Coccoris M; Bins A; Rodenko B; Gomez R; Nieuwkoop NJ; van de Kasteele W; Rimmelzwaan GF; Haanen JB; Ovaa H; Schumacher TN
Nat Med; 2006 Feb; 12(2):246-51. PubMed ID: 16462803
[TBL] [Abstract][Full Text] [Related]
4. UV-induced ligand exchange in MHC class I protein crystals.
Celie PH; Toebes M; Rodenko B; Ovaa H; Perrakis A; Schumacher TN
J Am Chem Soc; 2009 Sep; 131(34):12298-304. PubMed ID: 19655750
[TBL] [Abstract][Full Text] [Related]
5. Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long alpha helices.
Smith KD; Lutz CT
J Immunol; 1997 Mar; 158(6):2805-12. PubMed ID: 9058816
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional structures of MHC class I-peptide complexes: implications for peptide recognition.
Persson K; Schneider G
Arch Immunol Ther Exp (Warsz); 2000; 48(3):135-42. PubMed ID: 10912617
[TBL] [Abstract][Full Text] [Related]
7. MHC class I/peptide interactions: binding specificity and kinetics.
Margulies DH; Corr M; Boyd LF; Khilko SN
J Mol Recognit; 1993 Jun; 6(2):59-69. PubMed ID: 8305252
[TBL] [Abstract][Full Text] [Related]
8. Non-canonical anchor motif peptides bound to MHC class I induce cellular responses.
Lazoura E; Lodding J; Farrugia W; Day S; Ramsland PA; Apostolopoulos V
Mol Immunol; 2009 Mar; 46(6):1171-8. PubMed ID: 19118903
[TBL] [Abstract][Full Text] [Related]
9. Peptide binding by class I and class II MHC molecules.
Batalia MA; Collins EJ
Biopolymers; 1997; 43(4):281-302. PubMed ID: 9316393
[TBL] [Abstract][Full Text] [Related]
10. Structural prediction of peptides binding to MHC class I molecules.
Bui HH; Schiewe AJ; von Grafenstein H; Haworth IS
Proteins; 2006 Apr; 63(1):43-52. PubMed ID: 16447245
[TBL] [Abstract][Full Text] [Related]
11. Quantitative aspects of T cell activation--peptide generation and editing by MHC class I molecules.
Stevanović S; Schild H
Semin Immunol; 1999 Dec; 11(6):375-84. PubMed ID: 10625591
[TBL] [Abstract][Full Text] [Related]
12. Enhancing cytotoxic T cell responses with altered-peptide ligands.
Zhao R; Collins EJ
Arch Immunol Ther Exp (Warsz); 2001; 49(4):271-7. PubMed ID: 11726029
[TBL] [Abstract][Full Text] [Related]
13. Structural implications for the design of molecular vaccines.
Apostolopoulos V; Yu M; McKenzie IF; Wilson IA
Curr Opin Mol Ther; 2000 Feb; 2(1):29-36. PubMed ID: 11249650
[TBL] [Abstract][Full Text] [Related]
14. High-throughput T-cell epitope discovery through MHC peptide exchange.
Hadrup SR; Toebes M; Rodenko B; Bakker AH; Egan DA; Ovaa H; Schumacher TN
Methods Mol Biol; 2009; 524():383-405. PubMed ID: 19377960
[TBL] [Abstract][Full Text] [Related]
15. Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7.
Bakker AH; Hoppes R; Linnemann C; Toebes M; Rodenko B; Berkers CR; Hadrup SR; van Esch WJ; Heemskerk MH; Ovaa H; Schumacher TN
Proc Natl Acad Sci U S A; 2008 Mar; 105(10):3825-30. PubMed ID: 18308940
[TBL] [Abstract][Full Text] [Related]
16. Nonapeptide analogues containing (R)-3-hydroxybutanoate and beta-homoalanine oligomers: synthesis and binding affinity to a class I major histocompatibility complex protein.
Poenaru S; Lamas JR; Folkers G; López de Castro JA; Seebach D; Rognan D
J Med Chem; 1999 Jul; 42(13):2318-31. PubMed ID: 10395472
[TBL] [Abstract][Full Text] [Related]
17. Consensus motifs and peptide ligands of MHC class I molecules.
Falk K; Rötzschke O
Semin Immunol; 1993 Apr; 5(2):81-94. PubMed ID: 7684938
[TBL] [Abstract][Full Text] [Related]
18. Alloreactive T cells respond specifically to multiple distinct peptide-MHC complexes.
Felix NJ; Donermeyer DL; Horvath S; Walters JJ; Gross ML; Suri A; Allen PM
Nat Immunol; 2007 Apr; 8(4):388-97. PubMed ID: 17322886
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for a major histocompatibility complex class Ib-restricted T cell response.
Hoare HL; Sullivan LC; Pietra G; Clements CS; Lee EJ; Ely LK; Beddoe T; Falco M; Kjer-Nielsen L; Reid HH; McCluskey J; Moretta L; Rossjohn J; Brooks AG
Nat Immunol; 2006 Mar; 7(3):256-64. PubMed ID: 16474394
[TBL] [Abstract][Full Text] [Related]
20. Insights from MHC-bound peptides.
Margalit H; Altuvia Y
Novartis Found Symp; 2003; 254():77-90; discussion 91-101, 216-22, 250-2. PubMed ID: 14712933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
